POSTER COMMUNICATIONS
1983; Wiley; Volume: 78; Issue: S1 Linguagem: Francês
10.1111/j.1476-5381.1983.tb17361.x
ISSN1476-5381
Tópico(s)Biochemical Analysis and Sensing Techniques
ResumoBritish Journal of PharmacologyVolume 78, Issue S1 p. 88P-184P Free Access POSTER COMMUNICATIONS First published: March 1983 https://doi.org/10.1111/j.1476-5381.1983.tb17361.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat Galvan, M. & Scholfield, C.N. (1978). J.Physiol. 284, 129– 130P. Johnson, G.A.R., Kennedy, S.M.E. & Lodge, D. (1978). J. Neurochem. 31, 1519– 1523. Krogsgaard-Larsen, P. Johnson, G.A.R. Lodge, D. & Curtis, D.R. (1977) Nature 268, 53– 55. Scholfield, C.N. (1981) ed. G. A. Kerkut & H. Wheal Academic Press, pp 133– 151. Bowery N.G. et al. (1981). Europ.J.Pharmac., 71, 53– 70. Brown, D.A. & Marsh, S. (1978). Brain Res., 156, 187– 191. Desarmenien, M. et al. (1982). Br.J.Pharmac., 76, 289P. Hill, D.R. & Bowery, N.G. (1981). Nature, 290, 149– 152. Collard, K.J (1978) Br. J. Pharmac. 62, 137– 142. Harrison-Read, P.E. (1981) In: Neuroendocrine Regulation and Altered Behaviour. eds. P.D. Hrdina and R.L. Singhal, Croom-Helm, London, 224– 262. Fillion, G. and Fillion, M.P. (1981) Nature 292, 349– 351. Jones, R.S.G. (1981) Br. J. Pharmac. 73, 485– 493. Peroutka, S.J. and Snyder, S.H. (1981) Science 212, 827– 829. Creese, I. & Iversen, S.D. (1975) Brain Res. 83: 419– 436. Dyck, L.E., Boulton, A.A. & Jones, R.S. (1980) Eur. J. Pharmacol. 68: 33– 40. Molina, V.A. & Orsingher, O.A. (1981) Arch. int. Pharmacodyn. Ther. 251: 66– 79. Mueller, K. & Hsiao, S. (1980) Pharmacol. Biochem. Behav. 13: 627– 631. Scheel-Kruger, J. (1971) Eur. J. Pharmacol. 14: 47– 59. Horita, N. et al. (1981) Acta Neuropath. 53, 227. Llinas, R. et al. (1975) Science, 190, 1230. Mönier, H. and Okada, T. (1977) Life Sci. 20, 2101. Rommelspacher, H. et al. (1980) Arch. Pharmacol. 314, 97. Skolnick, P. et al. (1979) Pharm. Biochem. Behav. 10, 915. Bernard, P. et al. (1981) Pharmacologist 23, 150. Czernik, A.J. et al. (1982) Life Sci. 30, 363– 372. File, S.E. & Lister, R.G. (1982) Neuropharmacology, in press. File, S.E. & Lister, R.G. (1983) Pharmac. Biochem. Behav., in press. File, S.E. et al. (1982a) Neuropharmacology, 21, in press. File, S.E. et al. (1982b) Neuroscience Letters, in press. Hunt, P. et al. (1981) Proc. 8th Int. Congr. Pharmacol. Tokyo. Leyson, J.E. & Laduron, P.M. (1977) Arch. int. Pharmacodyn. 230, 337– 339. Middlemiss, D.N., et al. (1977) Nature 267, 289– 290. Peroutka, S.J. & Snyder, S.H. (1979) Mol. Pharmacol. 16, 687– 699. Heal, D.J. et al. (1981a) Neuropharmacology 20, 847. Heal, D.J. et al. (1981b) Eur.J.Pharmac. 75, 231. Keller, H.H. et al. (1974) Nature 248, 528. Miyamoto, M. & Nagawa, T. (1977) Eur.J.Pharmac. 44, 143. Costall, B. et al. (1972) Neuropharmac. 11, 317– 330. Costall, B. et al. (1982) Neuropharmac. 21, 327– 335. Puech, A.J. et al. (1981) Neuropharmac. 20, 1279– 1284. Hong, JS et al. (1978a) Neuropharmacology 171, 83. Hong, JS et al. (1978b) J.Pharm.Exp.Ther. 205,141. Murugaiah, K. et al. (1982) Nature 296, 570. Kebabian, J.W. & Calne, D.B. (1979) Nature (Lond.), 277, 93– 96. Marek, K.L. & Roth, R.H. (1980) Eur. J. Pharmac. 62, 137– 146. Walker, R.J. (1968) In, Expts. Physiol. Biochem.; edit G.A. Kerkut; pp 331– 345; Academic Press, London. Walker, R.J., Woodruff, G.N., Glaizner, B., Sedden, C.B. & Kerkut, G.A. (1968) Comp. Biochem. Physiol. 24, 455– 469. Woodruff, G.N. (1982) In, Adv. in Dopamine Res.; edit M. Kohsaka, T. Shohmori, Y. Tsukada & G.N. Woodruff; pp 1– 24; Pergamon Press, London. Bunney, B.S., Walters, J.R., Roth, R.H. and Aghajanian, G.K. (1973) J. Pharmac. Exp. Ther. 185, 560– 571. Euvrard, C., Ferland, L., DiPaolo, T., Beaulieu, M., Labrie, F., Oberlander, C., Raynaud, J.P. and Boissier, J.R. (1980) Neuropharmac. 19, 379– 386. Guyenet, P.G. and Aghajanian, G.K. (1978) Brain Res. 150, 69– 84. Miller, R.J. and Iversen, L.L. (1974) Naunyn-Schm. Arch. Pharmac. 282, 213– 216. Walters, J.R., Bunney, B.S. and Roth, R.H. (1975) Adv. Neurol. 9, 273– 284. Woodruff, G.N. and Freedman, S.B. (1982) Proc. Symp. on Dopamine Agonists, Stockholm, in press. Withy, R.M. et al. (1981) Biochem. Soc. Trans. 9, 416. James, D.T.D. et al. (1977) Neuroscience. 2, 1007– 1017. Scatton, B. et al. (1980) Neuroscience letts. 18, 125– 131. Stumpf, C. (1965). Int. Rev. Neurobiol. 8, 77– 138. Ahlenius, S. (1978) Brain Res. 150, 648– 652. Veening, J.G. et al. (1980) Neuroscience 5, 1253– 1268. Atterwill, C.K. (1981) Neuropharmacology 20 131– 144. Emlen, W., Segal, D.S. & Mandell, A.J. (1972) Brain Res. 77 471– 483. Gross, G., Brodde, O.E. & Schumann, H-J (1980) Eur. J. Pharmacol. 61 191– 194. Gross, G., & Schumann, H-J (1981) J. Pharm. Pharmacol. 33 552– 554. Heal, D.J., Akagi, H., Bowdler, J.M. & Green, A.R. (1981). Eur. J. Pharmacol. 75 231– 237. Strömbom, U., Svenson, T.H., Jackson, D.H. & Engstrom, G. (1977) J. Neural. Trans. 41 73– 92. U'Prichard, D.C., Reisine, T.D., Mason, S.T., Fibiger, H.C & Yamamura, H.I. (1980) Brain Res. 180 143– 154. Green, A.R. & Grahame-Smith, D.G. (1976) Nature 262, 594– 596. Middlemiss, D.N. et al. (1977) Nature 267, 289– 290. Peroutka, S.J. & Snyder, S.H. (1979) Mol. Pharmacol. 16, 687– 699. Peroutka, S.J. et al. (1981) Science 212, 827– 829. Berridge, M.J. (1981) Mol. Cell Endocrinol. 24, 115– 140. Berridge, M.J. et al. (1982) Biochem. J. (in press). Michell, R.H. et al. (1981) Phil. Trans. R. Soc. Lond. B. 296, 123– 137. Chapleo, C.B. et al. (1981) Brit. J. Pharmac. 842P. Langer, S.Z. (1980) Pharmacol. Rev. 32, 337. Jonsson et al. (1981) Eur. J. Pharmac. 72, 173. File, S. E. & Vellucci, S. V. (1978) J. Pharm. & Pharmac. 30, 105– 110. Hoehnsaric, R. et al. (1961) Arch. Gen. Psychiatry 38 (11), 1278– 1286. Montgomery, K. C. (1955) J. Comp. Physiol. Psychol. 48, 254– 260. Redmond, D. E. Jr. & Huang, Y. H. (1979) Life Sciences 25, 2144– 2162. Daniell, H.B. et al. (1979). J. Pharmac. Exp. Ther., 208, 354– 359. Gray, E.G. & Whittaker, V.P. (1962). J. Anat., 96, 79– 88. Middlemiss, D.N. et al. (1981). Pharmac. Ther., 12, 419– 437. Whittaker, V.P. et al. (1964). Biochem. J., 90, 293– 303. Collins, G.G.S. & Probett, G.A. (1981) Brain Res. 204, 231. Macrides, F. et al. (1981) J. comp. Neurol. 203, 495. Morley, M.J. & Kemp G.E. (1981) Brain Res. Rev. 3, 91. Pickles, H.G. & Simmonds, M.A. (1976) J. Physiol. 260, 475. Pickles, H.G. & Simmonds, M.A. (1973) J. Physiol. 275, 135. Rotter, A. et al. (1979) Brain Res. Rev. 1, 141. Croucher, M.J. et al. (1982) Sci. 216, 899. Evans, R.H. et al. (1982) Br. J. Pharmac. 75, 65. Perkins, M.N. et al. (1981) Neurosci. Lett. 23, 333. Watkins, J.C. & Evans, R.H. (1981) Ann. Rev. Pharmacol. Toxicol. 21, 165. Bolwig, T.D. et al. (1977) Eur.J.clin.Invest. 7, 95– 100. Cowen, P.J. & Nutt, D.J. (1982) Br.J.Pharmac. 75, 44P. Preskorn, S.H. et al. (1981) Science, 213, 469– 471. Pellegrino, L.J., Pellegrino, A.S., Cushman, A.J. (1981) Plenum Press, New York. Stone, T.W. & Perkins, M.N. (1981) Europ. J. Pharmac. 76, 411– 422. Greenberg, L.H. & Weiss, B. (1978) Science 201: 61– 63. Marwaha, J. et al. (1981) Neurobiol. Aging 2: 95– 98. Schmidt, M.J. & Thornberry, J.F. (1978) Brain Res. 139: 169– 177. Abood, L.G. et al. (1978) J. Neurosci. Res. 3, 327. Gray, E.G. & Whittaker, V.P. (1962) J. Anat. (Lond), 96, 79. Martin, B.R. & Aceto, M.D. (1981) Neurosci & Behav. Rev. 5, 473. Romano, C. & Goldstein, A. (1980) Science, 210, 647. Sershen, M. et al. (1981) J. Receptor Res. 2, 1. Yoshida, K. & Imura, H. (1979) Brain Res. 172, 453. Chin, J.H. et al. (1978) Biochim. Biophys. Acta 513, 358. Cotman, C.W. (1974) Methods of Enzymology vol. 31 p. 445 Academic Press, New York. Johnson, D.A. et al. (1979) Mol. Pharmacol. 15, 739. Lands, W.E.M. (1960) J. Biol. Chem. 235, 2233. Littleton, J.M. & John, G.R. (1977) J. Pharm. Pharmacol. 29, 579. P.T. Nhamburo et al. (in press) Biochem. Pharmacol. Sun, G.Y. et al. (1977) Res. Commun. Chem. Pathol. Pharmacol. 16, 753. Cox, B. & Ennis, C. (1980). Br. J. Pharmac. 70, 104P. Neely, J.R. et al. (1967) Amer.J. Physiol. 212, 804 p. Zannad, F. (1982) Eur. J. Pharmacol, in press. Clark, C. et al. (1980) J. Pharmacol. Methods, 3, 357. Fagbemi, O. et al. (1982) Br. J. Pharmac. 76, 504. Leprán, I. et al. (1979) Acta. Physiol. Acad. Sci. Hung. 53, 190. Rashid, S. & Waterfall, J.F. (1979) Gen. Pharmacol. 10, 459. Clark, C. et al. (1980) J. Pharmacol. Methods 3, 357. Hellstrom, R.H. (1979) Br. Heart J. 41, 426. Hearse, D.J., et al. (1978). J. Mol. Cell. Cardiol. 10, 641– 668. Zimmermann, A.N.E. & Hülsmann, W.C. (1966). Nature 211, 646– 647. Alabaster, C.T. and Henderson, C.G. (1982). Br. J. Pharmac., 76, Proc. Suppl. 251P. Ellis, P. and Joice, J.R. This meeting. Byrne, J.E., Gomoll, A.W. (1973) Fed. Proc. 32: 812. Byrne, J.E., Gomoll, A.W. and McKinney, G.R. (1977) J. Pharmacol. Exp. Ther. 200: 147– 154. Kates, R.E., Harrison, D.C. and Winkle, R.A. (1982) Clin. Pharmacol. Ther. 13: 4: 427– 432. Roden, D.M. et al., (1980) New England Journal of Medicine 302: 16: 875– 882. Casagrande C. et al., 7th International Symposium on Medicinal Chemistry, Torremolinos, Spain, Sept. 1980. Merlo L. et al., Symposium on Dopamine Receptor Agonists, Stockholm, Sweden, April, 1982. Chapleo et al. 1981 Br. J. Pharmac. 74, 842P. Dettmar, Lynn & Tulloch 1981 Br. J. Pharmac. 74, 843P. Docherty & Starke 1981 J. Cardlovasc. Res. 3, 854. Ahmed M. I. and Naylor I. L. (1982) Br. J. Pharmac. 77 538P. Chapleo et al., (1981) Br. J. Pharmac. 74 842P. McPherson G. A. and Summers R. J. (1982) Clin. Exp. Pharmac. and Physiol 9 77– 87. Chapleo C.B. et al. (1981). Br.J.Pharmac. 74, 842P. Constantine J.W. et al. (1980) Eur.J.Pharmac. 66, 281– 286. Clifford, J.M. et al. (1983). Br.J.Pharmac. This meeting.. Palay, V. Chan (1976) Brain Res. 102, 103– 133. Napoleone, P. et al. (1982) Neurosci. Letters 28, 57– 60. Vanhoutte, P.M. et al. (1981) Physiol. Rev. 61, 151– 247. Kuhn, D.M., Wolf, W.A. & Lovenberg, W. (1980) Hypertension 2, 243– 255. Vatner, S.F., Franklin, D. & Braunwauld, E. (1971) Am.J.Physiol., 220, 1249– 1255. van Nueten, J.M. & Vanhoutte, P.M. (1980) Eur.J.Pharmac. 64, 173. Kalkman, H.O. et al. (1982) Eur.J.Pharmac. 78, 107. Peroutka, S.J. & Snyder, S.H. (1981) J.Pharmac.Exp.Ther. 216, 142. Tbwart, R. (1981) Circ.Res. 48, 650. Kobinger, W. & Pichler, L. (1981) Eur.J.Pharmac. 76, 101. McGrath, J.C. (1982) Biochem.Pharmac. 31, 467. van Meel, J.C.A. et al. (1981) Naunyn-Schmiedeb.Arch.Pharmac. 316, 288. Timmermans, P.B.M.W.M. & van Zwieten, P.A. (1982) J.Med.Chem. in press. Thoolen, M.J.M.C. et al. (1981) Gen.Pharmac. 12, 303. Engberg, G. et al. (1982) Life Sci. 30, 235. Carswell, H. & Nahorski, S.R. (1982) Proc. Br. Pharmac. Soc. (Sunderland) C.65. Hawthorn, M.H. & Broadley, K.J. (1982) Naunyn-Schmiedebergs Arch. Pharmac. (in press). Zaagsma, J. et al. (1979) Catecholamines.Basic and Clinical Frontiers, Vol.1, 435, Pergamon Press. Perry, H.M. (1976) Review of hypertension induced in animals by chronic ingestion of cadmium. Trace elements in human health and disease vol II, ch 43. Academic Press, London. Perry, H.M., Erlanger, M. & Perry, E.F. (1980) Inhibition of cadmium induced hypertension in rats. Sci. Total Environ. 14, 153– 166. Brown, R.A. & O'Connor S.E. (1981) Br.J.Pharmac 73, 189P. Brown, R.A. et al. (1982) Proc.Int.Symp. on Dopamine Agonists, Stockholm. in press. Goldberg, L.I. et al. (1978) Ann.Rev.Pharmac.Toxicol. 18, 57– 79. Goldberg, L.I. et al. (1979) In: Catecholamines, Basic & Clinical Frontiers. Eds. Usdin E., Kopin I.J. & Barchas J. pp. 447– 449. Pergamon Press. McDermed, J.D. (1982) Proc.Int.Symp. on Dopamine Agonists, Stockholm. in press. Shepperson, N.B. et al. (1982) J. Pharmacol. exp. Therap. 221, 735– 761. Woodruff, G.N. (1982) TIPS February pp. 59– 61. Cavero, I. & Lefèvre-Borg, F. (1981) Br.J.Pharmac. 74, 927P. Cavero, I. et al. (1981a) J.Pharmacol.Exp.Ther. 218, 515– 524. Cavero, I. et al. (1981b) J.Pharmacol.Exp.Ther. 219, 510– 519. Goldstein, M. & Kinugasa, K. (1982) Pharmacologist 24, 137 (Abs. 240). Cavero, I. & Lefèvre-Borg, F. (1982) Br.J.Pharmac. (in press). Hicks, P.E. & Cannon, J.G. (1980) J.Pharm.Pharmacol. 32, 786– 788. Kitzen, J.M. et al. (1978) J.Pharmac.Exp.Ther. 206, 239– 247. Long, J.P. et al. (1975) J.Pharmac.Exp.Ther. 192, 336– 342. Boudot, J.P. et al. (1979) Br.J.Pharmac. 63, 445P. Buckingham, R.E. & Hamilton, T.C. (1979) Gen.Pharmac. 10, 1– 13. Cavero, I. (1983) This meeting. Lefèvre-Borg, F. & Cavero, I. (1980) Clin.Sci. 59, 291s– 294s. Prichard, B.N.C. (1978) Br.J.Clin.Pharmacol. 5, 379– 399. References Faden, A.I. and Holaday, J.W. (1979) Science 205 317– 318. Holaday, J.W., Ruvio, B.A., Robles, L.E. and Johnson, C.E. (1982). Life Science 31 (in press). Shaw, J.S., Miller, L., Turnbull, M.J., Gormley, J.J. and Morley, J.S. Life Science 31 (in press). Wheeler, H. (1982) Neuropharmacology (in press). Gormley J.J., et al. (1982) Life Sci. 31, 1263. Kosterlitz, H.W. et al. (1980) Br. J. Pharmac. 68, 333. Lord, J.A.H. et al. (1977) Nature 267, 495. Martin, W.R. et al. (1976) J. Pharmac. Exp. Ther. 197, 517. Shaw, J.S. and Turnbull, M.J. (1978) Eur. J. Pharmac. 49, 313. Shaw, J.S. et al. (1982) Life Sci. 31, 1259. Stockley, H. L. and Bennett A. (1974) Proc. 4th Int. Symp. on GI Motility. Ed: Daniel EE Mitchell Press, Vancouver. p 165– 176. Garry, R.C. & Gillespie, J.S. (1954) J. Physiol. 123, 60– 61P. Marshall, I. (1981) J. autonomic Pharmac. 1, 235– 250. Chapleo, C.B. et al. (1981) Br. J. Pharmac. 74, 842P. Baker, S. & Marshall, I. (1982) Br. J. Pharmac. 76, Proc. Suppl., 212P. Lattimer, N. et al. (1982) Br. J. Pharmac. 75, Proc. Suppl., 154P. Marshall, I. et al. (1978) Br. J. Pharmac. 62, 147– 151. Watanabe, Y. et al. (1982) Eur. J. Pharmac. 80, 105– 108. Engstrom, R.G. et al. (1975) Arch. int. Pharmacodyn. 214, 308. Gogerthy, J.H. et al. (1975) Arch. int. Pharmacodyn. 214, 285. Kruk, Z.L. & Zarrindast, M.R. (1976) Br. J. Pharmac. 58, 272p. Adebanjo, A.O. and Ambache, N. (1978) J. Physiol. (Lond)., 281, 28– 29P. Dismukes, R.K. et al. (1977) Naunyn Schmiedeberg's Arch Pharmacol., 299 115– 122. Wood, M.D. and Wyllie, M.G. (1981) J. Neurochem. 37 795– 797. Gillespie, J. (1972) Br. J. Pharmac. 45, 404– 416. Hughes, P.R. et al. (1982) Br. J. Pharmac. in press. Londos, C. et al. (1980) Proc. Nat. Acad. Sci. 77, 2551– 2554. Stone, T.W. (1981) Neuroscience 6, 523– 555. Van Calker, D. et al., (1979) J. Neurochem. 33, 999– 1005. Chapelo, C.B. et al. (1981), Br. J. Pharmac., 74, 842P. Docherty, J.R. et al. (1982) Arzneim. Forschung (Drug Res) (in press). Glossmann, H. et al. (1981), Naunyn-Schmied. Arch. Pharmac. 308, 319. Weitzell, R. et al. (1979), Naunyn-Schmied. Arch. Pharmac. 308, 127. Blaber, L.C. & Burden, D.T. (1982) Brit. J. Pharmacol. 76: 250P. Bowman, W.C. & Raper, C. (1976) J. Pharm. Pharmacol. 28: 369– 374. Daly, M.J. & Levy, G.P. (1979) Trends in Autonomic Pharmacology 1: 347– 4-19. ed. S. Kalsner Urban & Schwarzenberg. Baltimore. Augstein, J. et al. (1973). Nature new Biol., 245, 215– 217. Howe, R. & Shanks, R.G. (1966). Nature Lond., 210, 1336– 1338. Maclagan, J. & Ney, U.M. (1979). Eur. J. Pharmac., 66, 404– 418. Terpstra, G.K. et al., (1981). Eur. J. Pharmac., 73, 107– 108. Ainsworth, A. et al. (1982) Abstract North Amer. Med. Chem. Symposium, Toronto. Coates et al., (1982). Br. J. Pharmac., 75, 549– 552. Ismail et al., (1981). Br. J. Pharmac., 72, 535– 536P. Daigugi, M. (1981) Life Sci., 28, 2705– 2717. Elliot, J.M. & Grahame-Smith, D.G. (1980) Br, J. Pharmac., 70, 59P. Grant, J.A. & Scrutton, M.C. (1979) Nature, Lond., 277, 659– 661. Grant, J.A. & Scrutton, M.C. (1980) Br. J. Pharmac., 71, 121– 134. Hoffman, B.B. et al. (1979) Life Sci., 24, 1739– 1746. Hsu, C.Y. et al. (1979) J. Pharmac. exp. Therap., 208, 366– 375. Motulsky, H.J. & Insel, P.A. (1981) Clin. Res., 29, 275A. Drummond, A.H. (1976) in “Platelets in Biology and Pathology” ( J.L. Gordon, ed.) Elsevier/North Holland Biomedical Press, pp. 203– 239. Grant, J.A. & Scrutton, M.C. (1980) Brit. J. Pharmacol., 71, 121– 134. Kerry, R. & Scrutton, M.C. (1982) Brit. J. Pharmacol., in press. Yu, S.K. & Latour, J.G. (1977) Thrombosis and Haemostasis, 37, 413– 422. Berridge, M.J. & Heslop, J.P. (1981) Brit. J. Pharmacol., 73, 729– 738. Cusack, N.J. & Hourani, S.M.O. (1982) Brit. J. Pharmacol., 76, 221– 227. Jakobs, K.H., Saur, V. & Schultz, G. (1976) J. Cycl. Nucleotide Res., 2, 381– 392. Lasch, P. & Jakobs, K.H. (1979) Naunyn Schmiedeberg's Arch. Pharmacol., 306, 119– 125. Mills, D.C.B. (1975) CIBA Foundation Symp. No. 35 (new series) pp. 145– 167. Owen, N.E. & Le Breton, G.C. (1981) Am. J. Physiol., 241, H613– 666. Gerrard, J.M. et al. (1977) Am. J. Pathol. 86, 99– 115. Jones, R.L. et al. (1982) Br. J. Pharmac. 76, 423– 438. Maclntyre, D.E. (1981) Platelets in Biology and Pathology 2 (ed. J.L. Gordon) 211– 247. Lumley, P., Humphrey, P.P.A. (1981). J. Pharmacol. Methods, 6, 153. Vargas, J.R., Radomski, M. & Moncada, S. (1982). Prostaglandins, 23, 929. Whittle, B.J.R. et al.. (1980). Prostaglandins, 19, 605. Moore, P.K. & Hoult, J.R.S. (1980) Nature 288, 271. Barrett, K.E. et al. (1982) Br.J.Pharmac. 75, Proc. Suppl. 1P. Becker, EL. et al. (1981) In: Biochemistry of the Acute Allergic Reactions, ( A.R. Liss Inc, New York). Holgate, S.T. et al. (1980) J. Immunol. 124, 2093. Pearce, F.L. et al. (1979) In: The Mast Cell, its Role in Health and Disease, eds J. Pepys & A.M. Edwards ( Pitman, Tunbridge Wells) p 69. Robinson, C. et al. Biochim.Biophys.Acta (in press). Black, A.K. et al. (1978) Br.J.Clin.Pharmac. 5, 431. Hensby, C.N. et al. (1982) Int.J.Immunopharmac. 4, 352. Schalla, W. el al (1982) J.Invest.Dermatol. 78, 327. Abdel-Halim, M.S. et al. (1980) J. Neurochem. 34, 1331– 1333. Chapleau, C.E. & White, R.P. (1979) Prostaglandins 17, 573– 580. Coleman, R.A. et al. (1980) Br. J. Pharmac. 68, 127P– 128P. Jones, R.L. et al. (1982) Br.J. Pharmac. 76, 423– 438. Paul, K.S. et al., (1982) J. Neurosurg. 57, (in press). Augstein, J. et al. (1977) Agents and Actions 7, 443. Smith, D.A. & Neale, M.G. (1980) Toxicol Letts. Special Issue 1, 064. Scherrer, R.A. & Howard, S.M. (1977) J.Med.Chem. 20, 53. Winne, D. (1976) Experientia 32, 1278. Becker, R. (1977) Arzeim. Forsch. 27, 102. Tommasini, R. (1975) Curr. Med. Res. and Op. 3, Suppl. 1. Wahlin-Boll, E. & Almer, L.O. (1982) Clin. Pharm. 7, 362. Hensby, C.N. (1978) Clin. Exp. Dermatol. 3, 355. Herfst, M.J. et al. (1978) Arch. Dermatol. Res. 262, 1. Kolis, K.J. et al. (1978) Drug Metab. Dispos. 7, 220. Pathak, M.A. et al. (1974) J. Invest. Dermatol. 62, 347. Pathak, M.A. et al. (1977) “Psoriasis: Second International Symposium” ( E.M. Farber and A.J. Cox, eds) P262. Yorke Medical Book, New York. Steiner, I. et al. (1978) Acta Dermato-venerealogica 58, 185. Thune, P. & Volden, G. (1977) Acta Dermato-venerealogica 57, 351. Wulf, H.C. & Hart, J. (1979) Acta Dermato-venerealogica 59, 97. Arndts, D. et al. (1981) Eur. J. Clin. Pharmacol. 21, 201– 207. Harron, D.W.G. et al. (1981) Lancet i, 351–353. Rogerson, T.D. et al. (1977) Biochem. Pharmac. 26, 1039– 1042. Serlin, M.J. et al. (1979) Lancet ii, 317–319. Wilkinson, CF. et al. (1972) Biochem. Pharmac. 21, 3187– 3192. Ballantyne, B., (1977a) Med Annual, John Wright, Bristol. Ballantyne, B., (1977b) Toxicol 8 347. Colgrave, H. F. et al. (1979) Brit J Exper Pathol 55 213. Marrs, T. C. et al. (1982) Toxicol Lett in press. Upshall, D. G., (1974) Toxicol appl Pharmacol 29 301. Gubler, U. et al. (1982) Nature 295, 206– 208. Kakidani, H. et al. (1982) Nature 298, 245– 249. McKnight, A.T. et al. (1982) Eur.J.Pharmac. in press. Nahanishi, S. et al. (1979) Nature 278, 423– 427. Noda et al. (1982) Nature 295, 202– 206. Ainsworth, G.C., Brown, A.M. & Brownlee, G. (1949). Nature, 160, 263. Elmqvist, D. & Josefsson, J.O. (1962). Acta. Physiol. Scand. 54, 105– 110. Gale, E.F. (1963). Pharmacol. Rev. 15, 481– 530. Newton, B.A. (1956). Bact. Rev. 20, 14– 27. Salton, Y.N., & Tomasz, A. (1974). Ann.N.Y. Acad. Sci. 235, 1– 620. Singh, Y.N., Harvey, A.L. & Marshall, I.G. (1978). Anesthesiology, 48, 418– 424. Armstrong-James, M. & Millar, J. (1979) J. Neurosci. Meth. 1, 279– 87. Armstrong-James, M. et al. (1980) J. Neurosci. Meth. 2, 431– 2. Armstrong-James, M. et al. (1981) J. Neurosci. Meth. 4, 385– 406. Gonon, F.C et al. (1981) Anal. Chem. 53, 1386– 9. Kruk, Z.L et al. (1980) Life Sci. 27, 2093– 8. Plotsky, P.M. (1982) Brain Res. 235, 179– 84. Azzaro, A.J. & Smith, D.J. (1977) Neuropharm. 16, 349– 356. Brown, D.A. & Marsh, S. (1974) J. Physiol. 246, 24– 26P. Little, H.J. (1981) Br. J. Pharmac. 74, 880– 881P. Godfraind, T. & Dieu, D. (1981). J. Pharmacol, exp. Ther. 217, 510– 515. Jetley, M. & Weston, A.H. (1980). Br. J. Phamnac. 68, 311– 319. McDonald, T.F. et al. (1980). Pflügers Arch. 385, 175– 179. Weston, A.H. (1978). pp. 15– 22 in “Adrenoceptors” ed. E. Szabadi et al. Elsevier. Costall, B. et al. (1981). Br. J. Pharmac. 74, 179P– 180P. Sahyoun, H.A. et al. (1982a). J. Pharm. Pharmac. 34, 27– 33. Sahyoun, H.A. et al. (1982b). Naunyn-Schmiedeberg's Arch. Pharmac. 319, 8– 11. Collier, H.O.J, et al. (1981a) Br.J.Pharmac. 73, 443– 453. Collier, H.O.J, et al. (1981b) Br.J.Pharmac. 73, 921– 932. Griffith, S.G. et al. (1981) Eur.J.Pharmac. 75, 61– 64. Paton, D.M. (1981) J.Auton.Pharmac. 1, 287– 290. Van Calker, D. et al. (1979) J.Neurochem. 33, 999– 1005. Bond, A.M. & Hunt, J.N. (1956) J.Physiol. 133, 317– 329P. Fozzard, J.R. & Leach, G.D. (1968) Europ.J.Pharmac. 2, 239– 249P. Nicol, A.K. et al. (1981) J.Pharm.Pharmacol. 33, 554– 556P. Reed, J.D. & Smy, J.R. (1980) J.Physiol. 301, 39– 48P. Armstrong, J.M. et al. (1982) Proc. Br. Pharm. Soc. Stockholm. Bell, G.J. et al. (1977) Br. J. Pharmac. 61, 126P. Hardcastle, J. et al. (1981) J. Physiol. 320, 41– 56. Fozzard, J.R. & Leach, G.D.H. (1968) Europ. J. Pharm. 2, 239– 249. Thompson, J.H. (1971) Res. Comm. Chem. Path. 2, 687– 781. Whittle, B.J.R. & Main, I.H.M. (1973) Br. J. Pharmac. 49, 534– 542. Basran, G.S., Dewar, A., Morley, J., Page, C.P., Paul, W. & Wood, L. (1982). Brit J Pharmacol. 77 (suppl.) 437P. Boardman, L.E., Morley, J. & Sanjar, S. (1982). Brit J Pharmacol. 75 (suppl.) 144P. Cunningham, F.M. & Wood, L.E. Brit J Pharmacol. 77 (Suppl). 550P. Vargaftig, B.B., Lefort, J., Chignard, M. & Benveniste, J. (1980). European J Pharmacol. 65, 185– 192. Basran, G.S., et al. (1982) Amer. Rev. Respir. Dis. 52 (suppl.), 125. Humphrey, D., et al. (1982) Lab. Invest. 46, 422– 427. Majno, G.M. et al. (1967) Circulation Res. 21, 833– 847. Page, C.P. and Paul, W. (1982) Clin. Rheumatol. 1, 144. Vargaftig, B.B. et al. (1981) Ann. N.Y. Acad. Sci. 370, 119– 137. Cazenave JP, Benveniste J., Mustard JF (1979) Lab Invest 41: 275. Chignard M., Le Couedie JP, Tence M., Vargaftig BB, Benveniste J. (1979) Nature 279: 799. Chesney CM, Pifer DD, Byers LW, Muirhead EE (1982) Blood 59 (3): 582. McManus IM, Hanahan DJ, and Pinckard RN (1981) J Clin Invest 67: 903. Robbilee LS and Shepro D. (1976) Biochim. Biophys. Acta 436: 448. Shaw JD and Lyons RM (1982) Biochim. Biophys. Acta 714: 492. Vargaftig BB, Chignard MM, and Benveniste J. (1981) Biochem. Pharmacol. 30: 263. Vargaftig BB, Chignard MM, Benveniste J., Lefort J. and Wal F. (1981) Annals. N.Y. Acad. Sc. 370: 119. Chignard, M. et al. (1980) Br. J. Haemat. 46, 455– 464. Nunn, B., James, F.J. (1980) Br. J. clin. Pharmac. 9, 239– 245. Born, G.V.R. (1962) Nature, 194, 927– 929. Bucher, H.W. & Stucki, P. (1969) Experientia 25, 280– 282. Bouvenot, G. et al. (1980) Meditteranean Med. 218, 9– 14. Weksler, B.B. et al. (1977) Blood, 49, 185– 196. Cuthbert, A.W. & Spayne, J.A. (1982) Br.J.Pharmac. 76, 33– 35. Luscher, E.F. & Massini, P. (1975) In: Biochemistry and Pharmacology of Platelets. eds. K. Elliott & J. Knight Elsevier, Amsterdam pp. 5– 23. Moncada, S. (1982) Br.J.Pharmac. 76, 3– 31. Seamon, K. & Daly, J.W. (1981) J.biol.Chem. 10, 9799– 9801. Seamon, K., Padgett, W. & Daly, J.W. (1981) Proc.Natl.Acad.Sci. USA 78, 3363– 3367. Youdim, M.B.H. et al. (1981) Br.J.clin.Pharmac. 12, 535– 542. Volume78, IssueS1March 1983Pages 88P-184P ReferencesRelatedInformation
Referência(s)